Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Alnylam Pharmaceuticals Is Crashing Today

TheMotleyFool

0 0

Why Alnylam Pharmaceuticals Is Crashing TodayPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) were tanking on Thursday after the company reported its earnings results for the third quarter. The biopharmaceutical company's stock is down 14.1% as of 1:34 p.m. EDT, likely due to the company missing revenue estimates for the quarter.

The company also announced its CEO, John Maraganore, will be retiring at the end of 2021.

Image source: Getty Images.

Source Fool.com

Like: 0

ALNY

Teilen